IRL757, potential 1st apathy treatment, begins Phase 1 testing
Dosing has begun in a Phase 1 clinical trial evaluating the safety and efficacy of IRL757, an oral…
Read MoreExperience In Health
Dosing has begun in a Phase 1 clinical trial evaluating the safety and efficacy of IRL757, an oral…
Read MoreOlder Adult Health & Wellness Celebrations Set for Wednesday, May 29 Across the United States We are pleased…
Read MoreJoin Fox News for access to this content Plus special access to select articles and other premium content…
Read MorePro-skier Drew Petersen opens up about his past battles with depression and suicidal thoughts Pro-skier Drew Petersen opens…
Read MoreAsian Americans make up about 7% of the U.S. population and run some of the most popular restaurants…
Read MoreIndia’s AMA Herbal Group aims to “redefine the landscape of indigo dyeing” with a new alternative to synthetic…
Read More